Encorafenib with binimetinib for treating BRAF V600E mutation-positive advanced non-small-cell lung cancer [ID6177]

Draft guidance: 1

Draft guidance (downloadable version) (PDF 242 KB)

Draft guidance (online commenting)

Committee papers (PDF 6.67 MB)

Public committee slides (PDF 712 KB)

Final scope (PDF 182 KB)

Final stakeholder list (PDF 184 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 220 KB)